Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05881356 · ClinicalTrials.gov registry record
Discovering Factors in the Clinical Study Journey of Patients With OCD
A clinical trial of Obsessive - Compulsive Disorder and OCD, sponsored by Power Life Sciences.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT05881356: Recruiting study of Obsessive - Compulsive Disorder and OCD, sponsored by Power Life Sciences.
NCT05881356 is a study of Obsessive - Compulsive Disorder and OCD that is actively recruiting participants, run by Power Life Sciences. The registered enrollment target is 500 participants, below the 2,059-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05881356, a study of Obsessive - Compulsive Disorder and OCD, is actively recruiting participants, sponsored by Power Life Sciences.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This research aims to collect comprehensive data on the clinical trial experience of OCD patients. Its goal is to identify the factors that limit patients' ability to join or complete a trial successfully. Clinical trial participation often favors specific demographic groups, and limited research exists on the impact of trial attributes on participation. Therefore, this study aims to analyze data from various demographic groups and identify any recurring trends that could provide valuable insights for future OCD patients.
Conditions Studied
Study Locations (1)
California
- Power Life Sciences - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-06 |
| Est. Completion | 2026-06 |
What NCT05881356 shows while recruiting
NCT05881356 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 2,059-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT05881356 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05881356 about?
NCT05881356 is a clinical study titled "Discovering Factors in the Clinical Study Journey of Patients With OCD". This research aims to collect comprehensive data on the clinical trial experience of OCD patients. Its goal is to identify the factors that limit patients' ability to join or complete a trial successfully. Clinical trial participation often favors specific demographic groups, and limited research ex...
What is the current status of trial NCT05881356?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-06. Estimated completion is 2026-06.
What conditions does trial NCT05881356 study?
This clinical trial studies the following conditions: Obsessive - Compulsive Disorder, OCD.
Who is sponsoring clinical trial NCT05881356?
This trial is sponsored by Power Life Sciences, which has 62 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05881356 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive - Compulsive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05881356's enrollment target sits among peer trials
500 9th of 84 higher than 76 of 84 other Obsessive - Compulsive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obsessive - Compulsive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder
RECRUITING · NA
-
Mechanisms of Exposure Therapy for OCD
RECRUITING · NA
-
Using Personalized Assessments in the Treatment of Childhood OCD
RECRUITING · NA
-
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
RECRUITING · Phase 1
-
Neural Mechanisms of Response Inhibition Training for OCRD
RECRUITING · NA
-
MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia